New drug aims to limit heart damage after major attack
Disease control
Recruiting now
This study tests a medicine called Xolatryp in adults who have had a severe heart attack (STEMI) and are getting a procedure to open blocked arteries. Participants receive either a single 6-hour infusion of Xolatryp or a placebo, and their heart health is monitored for 30 days. T…
Phase: PHASE2 • Sponsor: Nyrada Pty Ltd • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC